Protalix BioTherapeutics, Inc.
PLX • AMEX
Protalix BioTherapeutics, Inc. is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Dror Bashan, with a market cap of $183.7M.
Market Cap$183.7M
Employees208.0
CEODror Bashan
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 8, 2026 · In 3 weeksQ1 2026
Financials
Protalix BioTherapeutics, Inc. FAQ
Common questions about Protalix BioTherapeutics, Inc.
Protalix BioTherapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 8, 2026. Analysts estimate revenue of $11.5M.
Protalix BioTherapeutics, Inc. has approximately 208 employees.